An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
Clinical trial NCT01929941 · TERMINATED
Trial details
- NCT number
- NCT01929941
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-08-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.